Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning
- 3 February 2014
- journal article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 49 (5), 720-721
- https://doi.org/10.1038/bmt.2014.5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugsHaematologica, 2011
- Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)British Journal of Haematology, 2010
- Second Unrelated Donor Hematopoietic Cell Transplantation for Primary Graft FailureTransplantation and Cellular Therapy, 2010
- Long-Term Follow-Up of Patients Who Experienced Graft Failure Postallogeneic Progenitor Cell Transplantation. Results of a Single Institution AnalysisTransplantation and Cellular Therapy, 2008
- Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantationHaematologica, 2008
- Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.2006
- CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failureBone Marrow Transplantation, 2005
- CD34+ immunoselected cells for poor graft function following allogeneic BMTCytotherapy, 2000
- Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantationBone Marrow Transplantation, 1998
- Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation.1993